Analyze Diet
American journal of veterinary research2004; 65(2); 173-178; doi: 10.2460/ajvr.2004.65.173

Concentrations of gentamicin in serum and bronchial lavage fluid after once-daily aerosol administration to horses for seven days.

Abstract: To assess gentamicin concentrations in serum and bronchial lavage fluid (BLF) of horses during a 24-hour period after once-daily aerosol administration of gentamicin (GAER) for 7 days and the pattern and degree of bronchial tree inflammation associated with repeated GAER. Methods: 13 healthy adult horses (9 geldings and 4 mares). Methods: The treatment group comprised 8 horses, and 5 horses were untreated control animals. Gentamicin (20 mL of gentamicin [50 mg/mL]) was administered via aerosol once daily for 7 days. Samples of serum and BLF were obtained from all horses before GAER and 0.5, 4, 8, and 24 hours after the final day of GAER. Gentamicin concentrations were determined for all samples from treated horses, and cytologic examinations were performed on all BLF samples. Results: Peak median BLF gentamicin concentration detected at 0.5 hours was 2.50 microg/mL. Median serum gentamicin concentration was < 0.50 microg/mL at all time points. Significant differences were not observed in total nucleated cell counts or differential cell counts in BLF between groups at any time point. Neutrophil count in BLF for all horses was increased over baseline at 4 and 24 hours. Conclusions: We did not detect evidence of gentamicin accumulation or respiratory inflammation after once-daily GAER for 7 days. This protocol appears unlikely to result in local or systemic toxicosis. Repeated daily GAER to horses appears to be a safe procedure and may have clinical use in the treatment of horses with bacterial infections of the airways.
Publication Date: 2004-02-21 PubMed ID: 14974574DOI: 10.2460/ajvr.2004.65.173Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study conducted on horses evaluated the concentrations of gentamicin in serum and bronchial lavage fluid following once-daily aerosol administration of this antibiotic for seven days, and also observed the bronchial tree inflammation related to such administration. No evidence of gentamicin accumulation or respiratory inflammation was detected, indicating that such treatment appears safe and may be clinically useful for treating horses with bacterial airway infections.

Study Design and Methodology

  • The study involved 13 healthy adult horses, with 8 horses in the treatment group and 5 horses serving as untreated controls.
  • Gentamicin, at a dosage of 20mL of a 50mg/mL solution, was administered via aerosol once a day for a week to the horses in the treatment group.
  • Samples of serum and bronchial lavage fluid (BLF) were taken from all horses at the start of the study and then at intervals of 0.5, 4, 8, and 24 hours after the seventh day of gentamicin administration.
  • The concentrations of gentamicin were measured in all the samples from the treated horses, and cytological analyses were performed on all BLF samples.

Results

  • The maximum median concentration of gentamicin detected in the BLF was 2.50 microg/mL at 0.5 hours post-administration.
  • The median concentration of gentamicin in serum was less than 0.50 microg/mL at all the time points measured.
  • No statistically significant differences were observed between the control and treatment groups in terms of total nucleated cell counts or differential cell counts in the BLF.
  • All horses displayed an increase in the neutrophil count in their BLF above the base level at 4 and 24 hours.

Conclusions

  • The researchers found no evidence of gentamicin accumulating or causing inflammation in the respiratory system after a seven-day course of once-daily aerosol administration.
  • This regimen does not appear to have the potential to cause local or systemic toxicosis.
  • The daily administration of aerosolized gentamicin appears to be a safe procedure, suggesting potential clinical utility in treating horses suffering from bacterial infections in their airways.

Cite This Article

APA
McKenzie HC, Murray MJ. (2004). Concentrations of gentamicin in serum and bronchial lavage fluid after once-daily aerosol administration to horses for seven days. Am J Vet Res, 65(2), 173-178. https://doi.org/10.2460/ajvr.2004.65.173

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 65
Issue: 2
Pages: 173-178

Researcher Affiliations

McKenzie, Harold C
  • Marion duPont Scott Equine Medical Center, Virginia-Maryland Regional College of Veterinary Medicine, Leesburg, VA 20177, USA.
Murray, Michael J

    MeSH Terms

    • Administration, Inhalation
    • Animals
    • Anti-Bacterial Agents / administration & dosage
    • Anti-Bacterial Agents / blood
    • Anti-Bacterial Agents / pharmacokinetics
    • Bronchoalveolar Lavage Fluid / chemistry
    • Gentamicins / administration & dosage
    • Gentamicins / blood
    • Gentamicins / pharmacokinetics
    • Horses / metabolism

    Citations

    This article has been cited 6 times.
    1. Minuto J, Bedenice D, Ceresia M, Zaghloul I, Böhlke M, Mazan MR. Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses. Front Vet Sci 2022;9:984108.
      doi: 10.3389/fvets.2022.984108pubmed: 36187809google scholar: lookup
    2. Durham AE. An evaluation of serum gentamicin concentrations and bacterial susceptibility to gentamicin in equine practice. J Vet Intern Med 2018 May;32(3):1194-1201.
      doi: 10.1111/jvim.15078pubmed: 29575239google scholar: lookup
    3. McConachie EL, Hart KA, Whelchel DD, Schroeder EL, Schott HC 2nd, Sanchez S. Pulmonary disease potentially associated with Nicoletella semolina in 3 young horses. J Vet Intern Med 2014 May-Jun;28(3):939-43.
      doi: 10.1111/jvim.12349pubmed: 24689696google scholar: lookup
    4. Hardefeldt L, Thomas K, Page S, Norris J, Browning G, El Hage C, Stewart A, Gilkerson J, Muscatello G, Verwilghen D, van Galen G, Bauquier J, Cuming R, Reynolds B, Whittaker C, Wilkes E, Clulow J, Burden C, Begg L. Antimicrobial prescribing guidelines for horses in Australia. Aust Vet J 2025 Dec;103(12):781-889.
      doi: 10.1111/avj.70003pubmed: 40903020google scholar: lookup
    5. Holley L, Creasey HN, Bedenice D, Reed S, Romualdo da Silva DR, Trautwein V, Mazan M, Widmer G. Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota. PLoS One 2025;20(1):e0316079.
      doi: 10.1371/journal.pone.0316079pubmed: 39854381google scholar: lookup
    6. Hallowell KL, Hepworth-Warren KL, Dembek K. An updated description of bacterial pneumonia in adult horses and factors associated with death. J Vet Intern Med 2024 Sep-Oct;38(5):2766-2775.
      doi: 10.1111/jvim.17141pubmed: 39005215google scholar: lookup